Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL370P is a **pseudogene** that originates from the gene for 7SL RNA, a key structural RNA component of the signal recognition particle (SRP) complex, which facilitates the targeting of proteins to the endoplasmic reticulum in eukaryotic cells[1][4]. Like most 7SL pseudogenes, RN7SL370P is a truncated, non-functional copy arising from retrotransposition events of 7SL RNA into the genome[3]. These pseudogenes are usually not expressed as functional RNAs or proteins, though a subset can be transcribed at low levels and, in rare cases, might regulate gene expression through RNA-based mechanisms, such as acting as competitive endogenous RNAs (ceRNAs) or miRNA sponges[2]. Importantly, **RN7SL370P itself does not encode a protein and is not a target for therapeutic intervention, nor is it generally considered to play a direct role in human disease**[1][4][3]. Its presence is primarily of interest in genomic studies of pseudogene evolution and non-coding RNA biology. Key context: - 7SL RNA (parent gene) is important for protein secretion and has roles in cancer and viral infection, but these functions do not directly apply to its many **pseudogenes** like RN7SL370P[5]. - The majority of 7SL-like sequences in the human genome are **pseudogenes**, with no significant, direct biological or therapeutic relevance[3]. - No known drugs, biomarkers, or disease associations are described for RN7SL370P[1][4][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 370, pseudogene (RN7SL370P).